Home/Pipeline/NeuroStar System & Software

NeuroStar System & Software

Platform Enhancement

R&DActive Development / Rollout

Key Facts

Indication
Platform Enhancement
Phase
R&D
Status
Active Development / Rollout
Company

About Neuronetics

Neuronetics' mission is to provide safe, effective neuromodulation therapies for patients with psychiatric disorders who have not benefited from first-line treatments. The company has achieved commercial success with its NeuroStar TMS system, establishing it as a leading brand with over 8.2 million treatments delivered and securing broad insurance coverage. Its strategy focuses on expanding clinical indications, driving provider adoption, and leveraging a razor-and-blades business model anchored in capital equipment sales and recurring revenue from treatment sessions.

View full company profile

Therapeutic Areas